Cargando…

Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

BACKGROUND: Cardiovascular comorbidity is common among patients with chronic obstructive pulmonary disease (COPD) and there is concern that long-acting bronchodilators (long-acting muscarinic antagonists (LAMAs) and long-acting beta(2) agonists (LABAs)) may further increase the risk of acute coronar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parkin, Lianne, Williams, Sheila, Barson, David, Sharples, Katrina, Horsburgh, Simon, Jackson, Rod, Dummer, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839854/ https://www.ncbi.nlm.nih.gov/pubmed/33495233 http://dx.doi.org/10.1136/bmjresp-2020-000840

Ejemplares similares

Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25–75/FVC) in COPD
por: Abston, Eric, et al.
Publicado: (2017)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population‐based nested case–control study
por: Parkin, Lianne, et al.
Publicado: (2021)

Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
por: Bowler, Russell, et al.
Publicado: (2019)

Time to NIV and mortality in AECOPD hospital admissions: an observational study into real world insights from National COPD Audits
por: Jayadev, Anita, et al.
Publicado: (2019)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

Are clinical risk scores for COPD useful?
por: Quint, Jennifer K
Publicado: (2015)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care
por: Lambe, Tosin, et al.
Publicado: (2019)

Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD
por: Key, Angela, et al.
Publicado: (2017)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017)

No association between DNA methylation and COPD in never and current smokers
por: de Vries, Maaike, et al.
Publicado: (2018)

Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake
por: Epton, Michael, et al.
Publicado: (2018)

ACE and response to pulmonary rehabilitation in COPD: two observational studies
por: Kon, Samantha S C, et al.
Publicado: (2017)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD
por: Grosbois, Jean-Marie, et al.
Publicado: (2022)

Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD
por: Garratt, Andrew Malcolm, et al.
Publicado: (2022)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD
por: Boutou, Afroditi K, et al.
Publicado: (2014)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
por: Maddocks, Matthew, et al.
Publicado: (2016)

Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
por: Marcon, Alessandro, et al.
Publicado: (2018)

Environmental triggers of COPD symptoms: a case cross-over study
por: Sama, Susan R, et al.
Publicado: (2017)

Adjuncts for sputum clearance in COPD: clinical consensus versus actual use
por: Barker, Ruth, et al.
Publicado: (2017)

Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis
por: Fermont, Jilles M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_avnlpij46336ht6m644toccbp1